Gahremanpour Amir, Perin Emerson C, Silva Guilherme
Division of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Tex Heart Inst J. 2012;39(4):474-87.
For about 2 decades, investigators have been comparing carotid endarterectomy with carotid artery stenting in regard to their effectiveness and safety in treating carotid artery stenosis. We conducted a systematic review to summarize and appraise the available evidence provided by randomized trials, meta-analyses, and registries comparing the clinical outcomes of the 2 procedures. We searched the MEDLINE, SciVerse Scopus, and Cochrane databases and the bibliographies of pertinent textbooks and articles to identify these studies. The results of clinical trials and, consequently, the meta-analyses of those trials produced conflicting results regarding the comparative effectiveness and safety of carotid endarterectomy and carotid stenting. These conflicting results arose because of differences in patient population, trial design, outcome measures, and variability among centers in the endovascular devices used and in operator skills. Careful appraisal of the trials and meta-analyses, particularly the most recent and largest National Institutes of Health-sponsored trial (the Carotid Revascularization Endarterectomy vs Stenting Trial [CREST]), showed that carotid stenting and endarterectomy were associated with similar rates of death and disabling stroke. Within the 30-day periprocedural period, carotid stenting was associated with higher risks of stroke, especially for patients aged >70 years, whereas carotid endarterectomy was associated with a higher risk of myocardial infarction. The slightly higher cost of stenting compared with endarterectomy was within an acceptable range by cost-effectiveness standards. We conclude that carotid artery stenting is an equivalent alternative to carotid endarterectomy when patient age and anatomy, surgical risk, and operator experience are considered in the choice of treatment approach.
在大约20年的时间里,研究人员一直在比较颈动脉内膜切除术和颈动脉支架置入术在治疗颈动脉狭窄方面的有效性和安全性。我们进行了一项系统评价,以总结和评估随机试验、荟萃分析及登记研究提供的有关这两种手术临床结局比较的现有证据。我们检索了MEDLINE、SciVerse Scopus和Cochrane数据库以及相关教科书和文章的参考文献以确定这些研究。临床试验的结果以及对这些试验的荟萃分析在颈动脉内膜切除术和颈动脉支架置入术的比较有效性和安全性方面产生了相互矛盾的结果。这些相互矛盾的结果是由于患者人群、试验设计、结局指标的差异,以及各中心在使用的血管内装置和术者技能方面的变异性所致。对这些试验和荟萃分析进行仔细评估,特别是对美国国立卫生研究院资助的最新且规模最大的试验(颈动脉血运重建内膜切除术与支架置入术试验[CREST])评估后发现,颈动脉支架置入术和内膜切除术的死亡和致残性卒中发生率相似。在围手术期30天内,颈动脉支架置入术的卒中风险较高,尤其是对于年龄>70岁的患者,而颈动脉内膜切除术的心肌梗死风险较高。与内膜切除术相比,支架置入术略高的费用按成本效益标准在可接受范围内。我们得出结论,在选择治疗方法时,考虑患者年龄和解剖结构、手术风险及术者经验的情况下,颈动脉支架置入术是颈动脉内膜切除术的等效替代方法。